With over 685 companies globally, 669 current clinical trials and the European approval for the sale of GSK’s Strimvelis, 2016 has already proven the fast pace at which the cell and gene therapy markets are both moving and growing.
Join more than 200 industry experts from across the globe at Informa’s Cell Therapy Manufacturing and Gene Therapy Congress on the 29th-30th November 2016, Amsterdam to find out how industry pioneers are working with current regulations to bring new products to market, industry leading technical and commercial strategies to delivering cell and gene therapy products to patients, and how to fast-track to success.
Learn and benchmark with attendees from the main cell, gene & immunotherapy communities:
• Optimise your process, manufacturing capabilities and analytical strategies
STREAM 1: Cell, Gene and Immunotherapy Manufacturing, Process Optimization and Analytics
• Ensure stringent cold chain and process automation strategies
STREAM 2: Cell, Gene and Immunotherapy Manufacturing, Process Automation and Cold Chain
• Learn how to accelerate preclinical studies and push products into the clinic
STREAM 3: Preclinical Strategies for Cell, Gene and Immunotherapies
• Successful clinical strategies and regulatory intelligence for efficient development
STREAM 4: Clinical Development for Cell, Gene and Immunotherapies
For more information and online registration please visit the congress website at https://lifesciences.knect365.com/
ARM Member Discount: As a valued member of ARM you are entitled to an exclusive 25% discount* to attend the event. To claim the discount, just quote your VIP code CQ3561ARM upon registration online. To find out more about discount click here: http://get.knect365.com/cq3561arm/
